A detailed history of Jefferies Financial Group Inc. transactions in Nkarta, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 250,000 shares of NKTX stock, worth $612,500. This represents 0.01% of its overall portfolio holdings.

Number of Shares
250,000
Previous 250,000 -0.0%
Holding current value
$612,500
Previous $1.48 Million 23.49%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$5.27 - $10.82 $1.05 Million - $2.16 Million
200,000 Added 400.0%
250,000 $1.48 Million
Q1 2024

May 13, 2024

SELL
$5.59 - $15.71 $1.12 Million - $3.14 Million
-200,000 Reduced 80.0%
50,000 $540,000
Q3 2023

Nov 14, 2023

BUY
$1.39 - $2.29 $347,500 - $572,500
250,000 New
250,000 $347,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $119M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.